Skyn Endurance Delay For Men
NDC Package 73115-000-01
Package Information
Skyn Endurance Delay For Men is a . Marketed by Sxwell Usa, Llc, this product is identified by NDC 73115-000 and is authorized under FDA application part348.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 73115 - Sxwell Usa, Llc
- 73115-000 - Skyn Endurance Delay For Men
- 73115-000-01 - 1 BOTTLE in 1 BOX / 5.1 mL in 1 BOTTLE
- 73115-000 - Skyn Endurance Delay For Men
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 73115-000-01 identifies a specific commercial package of 1 bottle in 1 box / 5.1 ml in 1 bottle of Skyn Endurance Delay For Men, labeled by Sxwell Usa, Llc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Sxwell Usa, Llc on June 01, 2019. The current certification is valid through September 15, 2022.
How is this Sxwell Usa, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 73115000001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.